Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) Reported Basic Consolidated EPS Of $-0.6746 For Period Ended 2015-12-31

0

The annual basic consolidated EPS for Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) for the period ended 2015-12-31 was $-0.6746. On quarterly basis, the basic consolidated EPS reading for the quarter ended 2015-12-31 was $-0.6746.

EPS from continuing operations

Coming to basic EPS from continuing operations, Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) reported $-0.6746 for the annual period ended 2015-12-31. Quarterly basic EPS from continuing operations for the three-month period ended 2015-12-31 stood at $-0.6746.

EPS contribution from parent

For the annual period ended 2015-12-31, Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) received basic EPS of $-0.6746 from its parent company. On quarterly basis, basic EPS contribution from the parent company for the period ended 2015-12-31 was $-0.6746.

Basic net EPS

For the annual period ended 2015-12-31, Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) reported basic net EPS of $-0.67. On quarterly basis, the company’s basic net EPS for the three-month period ended 2015-12-31 stood at $-0.67.

Consolidated diluted EPS

The annual consolidated diluted EPS reading for the period ended 2015-12-31 stood at $-0.6746. For the quarter ended 2015-12-31, consolidated diluted EPS was $-0.6746.

Basic diluted EPS

On annual basis, diluted EPS reading from continuing operation was $-0.6746 for the period ended 2015-12-31. Diluted EPS from continuing operations for the quarter ended 2015-12-31 was $-0.6746.

Net diluted EPS

Net diluted EPS reading for the annual period ended 2015-12-31 was $-0.67. For the quarterly period ended 2015-12-31, net diluted EPS was $-0.67.

Diluted EPS from parent

From the parent company, Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) received diluted EPS of $-0.6746 for the annual period ended 2015-12-31. On quarterly basis, diluted EPS contribution from the parent for the quarter ended 2015-12-31 was $-0.6746.

Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) posted net basic EPS reading of $-0.67 for the annual period ended 2015-12-31. For the quarter, basic net EPS of $-0.67 was for the quarter ended 2015-12-31.

Net diluted EPS for Sagent Pharmaceuticals, Inc. (NASDAQ:SGNT) for the annual period ended 2015-12-31 was $-0.67. The company also reported net diluted EPS reading of $-0.67 for the quarter ended 2015-12-31.

The annual average basic shares outstanding for the period ended 2015-12-31 is 32.439 while for the quarter ended 2015-12-31 is 32.439.

The diluted shares outstanding for the fiscal year ended is 2015-12-31 is 32.439 while for the quarter ended 2015-12-31 is 32.439.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 31 times, 1 visits today)